IART Integra LifeSciences Holdings C | US4579852082
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 1.730.108.520 | 1.676.066.730 | 3.22% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 2,62 | 2,45 | 6.86% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 11 | 11 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |